Cargando…

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis

BACKGROUND: Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of follow-up are limited. Here, we describe the large European MultiPartner IPF Registry (EMPIRE) and validate predictors of long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Tanja, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R., Jovanović, Dragana, Tekavec-Trkanjec, Jasna, Studnicka, Michael, Stoeva, Natalia, Hejduk, Karel, Dušek, Ladislav, Suissa, Samy, Vašáková, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951015/ https://www.ncbi.nlm.nih.gov/pubmed/31915023 http://dx.doi.org/10.1186/s12931-019-1271-z

Ejemplares similares

Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries
por: Kolonics-Farkas, Abigél Margit, et al.
Publicado: (2021)

Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE
por: Kolonics-Farkas, Abigél M., et al.
Publicado: (2020)

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
por: Jovanovic, Dragana M., et al.
Publicado: (2022)

Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone
por: Májek, Ondřej, et al.
Publicado: (2022)

A young man with transitory hemiparesis and lung infiltrates
por: Ljilja, Anja, et al.
Publicado: (2021)

Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias
por: Bruzova, Magdalena, et al.
Publicado: (2021)

Role of interleukin 4 and its receptor in clinical presentation of chronic extrinsic allergic alveolitis: a pilot study
por: Sterclova, Martina, et al.
Publicado: (2013)

Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients
por: Sterclova, Martina, et al.
Publicado: (2019)

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry
por: Zurkova, Monika, et al.
Publicado: (2019)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment
por: Sterclova, Martina, et al.
Publicado: (2021)

PAR-2, IL-4R, TGF-β and TNF-α in bronchoalveolar lavage distinguishes extrinsic allergic alveolitis from sarcoidosis
por: MATĚJ, RADOSLAV, et al.
Publicado: (2014)

New Partner, New Order? Multipartnered Fertility and Birth Order Effects on Educational Achievement
por: Lillehagen, Mats, et al.
Publicado: (2020)

Multipartner Symbiosis across Biological Domains: Looking at the Eukaryotic Associations from a Microbial Perspective
por: Turon, Marta, et al.
Publicado: (2019)

An Innovative Multipartner Research Program to Address Detection, Assessment and Treatment of Neonatal Infections in Low-resource Settings
por: Qazi, Shamim Ahmad, et al.
Publicado: (2013)

A Successful National and Multipartner Approach to Increase Immunization Coverage: The Democratic Republic of Congo Mashako Plan 2018–2020
por: Lame, Paul, et al.
Publicado: (2023)

Notes from the Field: A Multipartner Response to Prevent a Binational Rabies Outbreak — Anse-à-Pitre, Haiti, 2019
por: Adrien, Joane, et al.
Publicado: (2019)

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
por: Guenther, Andreas, et al.
Publicado: (2018)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease
por: Schamberger, Andrea C., et al.
Publicado: (2016)

IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study
por: Fox, Benjamin D., et al.
Publicado: (2019)

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
por: Raghu, Ganesh, et al.
Publicado: (2022)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Coverage by examinations associated with early detection of colorectal neoplasia in the Czech Republic
por: Ngo, Ondřej, et al.
Publicado: (2023)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
por: Radić, Mislav, et al.
Publicado: (2022)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

The Role of Immunity and Inflammation in IPF Pathogenesis
por: Butler, Marcus W., et al.
Publicado: (2018)

Senescent Cells in IPF: Locked in Repair?
por: Meiners, Silke, et al.
Publicado: (2020)

IPF in Saudi Arabia: Lessons for all
por: Nathan, Steven D.
Publicado: (2020)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hsldo5523k312smlh9rerqi1se